![]() |
市場調査レポート
商品コード
1619061
マイクロバイオームシーケンスサービス市場規模、シェア、成長分析、サービス別、技術別、地域別 - 産業予測、2024~2031年Microbiome Sequencing Services Market Size, Share, Growth Analysis, By Service (Sample Preparation, Sequencing and Library Preparation), By Technology (Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL)), By Region - Industry Forecast 2024-2031 |
||||||
|
マイクロバイオームシーケンスサービス市場規模、シェア、成長分析、サービス別、技術別、地域別 - 産業予測、2024~2031年 |
出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
マイクロバイオームシーケンスサービスの世界市場規模は、2022年に13億7,000万米ドルと評価され、2023年の15億2,000万米ドルから2031年には34億8,000万米ドルに成長し、予測期間中(2024~2031年)のCAGRは10.9%で成長する見通しです。
マイクロバイオームシーケンスサービス市場は、遺伝子技術の進歩、健康におけるヒトマイクロバイオームの役割に対する認識の高まり、個別化医療に対する需要の高まりによって急速な成長を遂げています。微生物コミュニティと全体的な健康との関係を強調する調査は、自身のマイクロバイオームを理解することへの消費者の関心を煽り、シーケンスサービスのニーズを高めています。このようなサービスは、様々な疾患に対するマイクロバイオームベースの薬剤の出現により、治療において不可欠なものとなりつつあります。トランスクリプトミクス、メタボロミクス、ゲノムデータを組み合わせたマルチオミクスアプローチの人気は研究成果を高め、細菌とヒトの健康との複雑なつながりを強化しています。さらに、増え続ける微生物ゲノムデータの処理にはバイオインフォマティクスの進歩が必要であり、正確な診断への道を開き、環境研究や農業への応用を強化します。
Global Microbiome Sequencing Services Market size was valued at USD 1.37 billion in 2022 and is poised to grow from USD 1.52 billion in 2023 to USD 3.48 billion by 2031, growing at a CAGR of 10.9% during the forecast period (2024-2031).
The market for microbiome sequencing services is experiencing rapid growth driven by advancements in genetic technology, increased awareness of the human microbiome's role in health, and a rising demand for personalized medicine. Research highlighting the relationship between microbial communities and overall health fuels consumer interest in understanding their own microbiomes, thus elevating the need for sequencing services. These services are becoming integral in medical treatments, with microbiome-based medications for various diseases emerging. The popularity of multi-omics approaches-combining transcriptomics, metabolomics, and genomic data-enhances research outcomes, reinforcing the intricate connection between bacteria and human health. Additionally, advancements in bioinformatics are needed to process growing microbial genomic data, paving the way for accurate diagnoses and enhancing applications in environmental studies and agriculture.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbiome Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Microbiome Sequencing Services Market Segmental Analysis
Global Microbiome Sequencing Services Market is segmented by service, technology, application, end user and region. Based on service, the market is segmented into Sample Preparation, Sequencing and Library Preparation, and Data Analysis. Based on technology, the market is segmented into sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, sanger sequencing and others. Based on application, the market is segmented into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing and others. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, hospitals and clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Microbiome Sequencing Services Market
The global microbiome sequencing services market is significantly driven by the rising demand for personalized medicine. As healthcare increasingly shifts towards tailored approaches for individuals, microbiome analysis becomes essential in understanding the unique composition of microorganisms within each patient. This targeted analysis aids in the accurate diagnosis and effective management of various health conditions, enhancing treatment outcomes. Consequently, the growing emphasis on personalized healthcare solutions is fueling the expansion of the microbiome sequencing services market, as more healthcare professionals seek to incorporate these advanced analytical techniques into their practices to optimize patient care.
Restraints in the Global Microbiome Sequencing Services Market
A major constraint facing the Global Microbiome Sequencing Services market is the prohibitive cost associated with sequencing. Despite advancements in technology, the expenses related to sequencing equipment, reagents, and data analysis remain substantial. This financial barrier poses challenges for smaller research institutions and clinics, making it difficult for them to access and implement these services. As a result, the high costs hinder widespread adoption and utilization of microbiome sequencing, ultimately stifling the growth prospects of the market and limiting opportunities for innovation and research in the field.
Market Trends of the Global Microbiome Sequencing Services Market
The global microbiome sequencing services market is experiencing a significant trend toward the integration of Artificial Intelligence (AI) and machine learning technologies. This shift enhances the analysis of complex microbiome data, facilitating a deeper understanding of microbial interactions and their implications for health and disease prevention. As AI-driven tools become more prevalent, they enable researchers and healthcare professionals to derive actionable insights from vast amounts of sequencing data, leading to improved therapeutic strategies and personalized medicine approaches. Consequently, the demand for advanced microbiome analysis services is anticipated to surge, reflecting a broader movement towards data-driven solutions in life sciences and healthcare sectors.